FDA
-
-
-
-
-
-
-
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
-
-
-
-
-
-
-
Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
-
-
-
-
-
-
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
-
-
-
-
-
-
-
Pacira BioSciences completes enrollment in knee osteoarthritis gene therapy trial
-
-
-
-
-
-
-
Pacira BioSciences to present 3-year PCRX-201 gene therapy data at conference
-
-
-
-
-
-
-
Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee
-
-
-
-
-
-
-
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
-
333,553 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


